Keith Katkin Rigel Pharmaceuticals Inc (RIGL) insider trading activity

RIGL Quotes by TradingView

Keith Katkin is Director of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 25,000 shares of RIGL, which is worth approximately $411,000. The most recent transaction as insider was on May 19, 2021, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K
0% 3M change
0% 12M change
Total Value Held $411,000

Keith Katkin Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock

Also insider at

SNDX
Syndax Pharmaceuticals Inc Healthcare
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
Director
EBS
Emergent BioSolutions Inc. Healthcare
Director
KK

Keith Katkin

Director
Gaithersburg, MD

Track Institutional and Insider Activities on RIGL

Follow RIGEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RIGL shares.

Notify only if

Insider Trading

Get notified when an Rigel Pharmaceuticals Inc insider buys or sells RIGL shares.

Notify only if

News

Receive news related to RIGEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RIGL